Cargando…

Serotonin Antagonism Improves Platelet Inhibition in Clopidogrel Low-Responders after Coronary Stent Placement: An In Vitro Pilot Study

Increased residual platelet reactivity remains a burden for coronary artery disease (CAD) patients who received a coronary stent and do not respond sufficiently to treatment with acetylsalicylic acid and clopidogrel. We hypothesized that serotonin antagonism reduces high on-treatment platelet reacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duerschmied, Daniel, Ahrens, Ingo, Mauler, Maximilian, Brandt, Christoph, Weidner, Stefanie, Bode, Christoph, Moser, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287984/ https://www.ncbi.nlm.nih.gov/pubmed/22384279 http://dx.doi.org/10.1371/journal.pone.0032656

Ejemplares similares

Serotonin: a platelet hormone modulating cardiovascular disease
por: Rieder, Marina, et al.
Publicado: (2020)

The Effects of Serotonin in Immune Cells
por: Herr, Nadine, et al.
Publicado: (2017)

Acute Fluoxetine Treatment Induces Slow Rolling of Leukocytes on Endothelium in Mice
por: Herr, Nadine, et al.
Publicado: (2014)

Correction: Acute Fluoxetine Treatment Induces Slow Rolling of Leukocytes on Endothelium in Mice
por: Herr, Nadine, et al.
Publicado: (2015)

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2019)

Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACS
por: Heger, Lukas Andreas, et al.
Publicado: (2019)

Platelets in Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2022)

Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury
por: Starz, Christopher, et al.
Publicado: (2022)

Ulcerative livedoid vasculopathy responding to clopidogrel
por: Kunzler, Elaine, et al.
Publicado: (2018)

Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
por: Dias, Joao D., et al.
Publicado: (2019)

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
por: Ahrens, Ingo, et al.
Publicado: (2014)

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
por: Berger, Peter B
Publicado: (2000)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019)

Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment
por: Heger, Lukas Andreas, et al.
Publicado: (2022)

Hospital Variation in Premature Clopidogrel Discontinuation After Drug‐Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System
por: Vigen, Rebecca, et al.
Publicado: (2016)

Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)

Extracellular HtrA2 Induces Apoptosis in Human Umbilical Vein Endothelial Cells
por: Kaur, Gurpinder, et al.
Publicado: (2019)

Thrombin Receptor Antagonism in Antiplatelet Therapy
por: Olivier, C., et al.
Publicado: (2013)

The Impact of Generic Clopidogrel Bisulfate on Platelet Inhibition in Patients with Coronary Artery Stents: Results of the ACCEL-GENERIC Study
por: Jeong, Young-Hoon, et al.
Publicado: (2010)

Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis
por: Diehl, Philipp, et al.
Publicado: (2015)

Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis
por: Supady, Alexander, et al.
Publicado: (2020)

Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion
por: Cohn, Stephen M, et al.
Publicado: (2019)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018)

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
por: Olivier, Christoph B., et al.
Publicado: (2016)

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study
por: Heger, Lukas Andreas, et al.
Publicado: (2020)

Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry
por: Staudacher, Dawid L., et al.
Publicado: (2015)

Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders
por: Lee, Seung-Hyun, et al.
Publicado: (2013)

Effects of clopidogrel and prednisone on platelet function in healthy dogs
por: Thomason, John, et al.
Publicado: (2020)

Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
por: Kille, Alexander, et al.
Publicado: (2021)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Gjermeni, Diona, et al.
Publicado: (2022)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
por: Wykrzykowska, Joanna J., et al.
Publicado: (2009)

Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
por: Godino, Cosmo, et al.
Publicado: (2009)

Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury
por: Jank, Marietta, et al.
Publicado: (2021)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis
por: Heger, Lukas Andreas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_evk4vledilkpql37r4b7los9fp